top of page
Search
Glenn Hearson
Nov 7, 2016
Understanding the mechanisms of idiopathic pulmonary fibrosis in order to develop new treatments
IPF is a progressive and devastating lung disorder characterised by irreversible scarring (fibrosis) of the lung. IPF affects over 8,000 peo
65
Glenn Hearson
Nov 4, 2016
Creating “Breathing” Lung Slices in the Laboratory
Many research groups around the world use thin slices of lung tissue to investigate asthma and other respiratory diseases. Lung slices...
53
Glenn Hearson
Oct 27, 2016
Klaudia Kaczmarek: Inhibiting PMRTs in Asthma
Klaudia Kaczmarek is a PhD student working in Nottingham City Hospital, supervised by Professor Alan Knox and Dr Rachel Clifford . Her...
152
Glenn Hearson
Oct 21, 2016
Amanda Goodwin: Targeting Myofibroblast Mechanotransduction to prevent Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a long-term chest condition that is characterised by fibrosis (scarring) of the lungs, which...
51
Glenn Hearson
Oct 21, 2016
Rachel Clifford: Epigenetics of Lung Disease
I am interested in the epigenetics of lung disease, primarily asthma. Epigenetics refers to a group of processes that control how and...
104
Glenn Hearson
Sep 4, 2016
Amplification of TGFβ Induced ITGB6 Gene Transcription May Promote Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a devastating, progressive disease with poor survival rates and limited treatment options. Upregulati
24
Glenn Hearson
Jul 15, 2016
Caffeine inhibits TGFβ activation in epithelial cells, interrupts fibroblast responses to TGFβ
Caffeine inhibits TGFβ activation in epithelial cells, interrupts fibroblast responses to TGFβ
14
Glenn Hearson
May 28, 2016
Reduced Ets Domain-containing Protein Elk1 Promotes Pulmonary Fibrosis via Increased Integrin αvβ6
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with high mortality. Active TGFβ1 is considered central to the pa
14
bottom of page